You are here: Industry Insights > DMC

News List

Innovation Pharma to increase dosing frequency in Covid-19 drug trial pharmaceutical-technology
April 07, 2021
Innovation Pharmaceuticals is set to increase dosing frequency in Phase II clinical trial of a drug candidate, Brilacidin, for treating moderate-to-severe Covid-19 in hospitalised patients.
Apellis Will Not Peruse Development of APL-9 for Severe COVID-19 americanpharmaceuticalreview
March 10, 2021
Apellis Pharmaceuticals announced the company will not pursue additional development of APL-9, an investigational targeted C3 therapy designed for acute interventions, for the treatment of severe COVID-19.
Regeneron to continue patient recruitment for Covid-19 trial pharmaceutical-technology
November 09, 2020
The independent data monitoring committee (DMC) has recommended the continuation of Regeneron’s UK-based RECOVERY trial analysing REGN-COV2 in hospitalised patients with Covid-19.
Independent DMC Recommends Trial Discontinuation of Staphylococcus aureus Vaccine americanpharmaceuticalreview
December 29, 2018
Pfizer announced the Phase 2b trial STRIVE (STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy) evaluating the company’s investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) is being discontinued due to futility....
Legend Capital co-invests $293M in Chinese DMC biospectrumasia
August 03, 2018
Chinese Diagnostics Medical Corporation specializes in the design and development of diagnostic testing reagents.